Surprisingly, several reports have indicated that selective CDK8 inhibitors were inactive on colorectal cancer (CRC) cell lines with amplification of CDK8, which were previously characterized as being sensitive to CDK8 gene silencing [5, 6]. Here, CDK8 is linked to colorectal cancer.